This is a preview of subscription content, log in via an institution to check access.
Notes
Speedy Opening of Non-functional and Occluded catheters with Mini-dose Alfimeprase-3.
References
Clinical Data. Clinical Data Initiates pivotal phase III trial for novel antidepressant. first ever pharmacogenomic screening tool for antidepressant to be developed concurrently. Media release: 26 Jan 2006
Lorenzo A. Clinical Data to test phase III tandem of vilazodone, marker [online]. BioWorld Today; 2006 Jan 27. Available from URL: http://www.clda.com/Press_Releases/CLDA%20-%20Bioworld%20-%20012706.pdf [Accessed 2006 Mar 20]
Nuvelo. Nuvelo and Bayer HealthCare begin SONOMA-3, second phase 3 trial of alfimeprase in patients with central venous catheter occlusion. Media release: 27 Feb 2006
CEL-SCI. CEL-SCI receives U.S. patent for use of L.E.A.P.S(TM) technology for autoimmune conditions and allergies. Media release: 28 Feb 2006
Agilent Technologies. Trade News: Agilent Technologies launches ion trap mass spectrometer with powerful new tool for study of proteins. Media release: 13 Mar 2006
Bruker Daltonics. Bruker Daltonics introduces new MALDI Molecular ImagerTM for in-vitro imaging of protein biomarkers in tissue sections and cell clusters. Media release: 10 Mar 2006
Rights and permissions
About this article
Cite this article
Recent R&D Highlights. Pharmaceutical & Diagnostic Innovation 4, 17–18 (2006). https://doi.org/10.1007/BF03257053
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257053